Molecular modeling studies of interaction between plasmid DNA (pBR322) and dendritic antioxidants

Journal of Cancer Science and Therapy

Volumn 3, Issue 9, 2011, Pages 220-227

  Chhetri, Pratik ^a   Lee, Choon ^a   Rakesh, Leela ^a  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 IODOVANILLIN; ANTIOXIDANT; ASCORBIC ACID; DOUBLE STRANDED DNA; PBR322 DNA; PLASMID DNA; QUERCETIN; UNCLASSIFIED DRUG; VANILLIN;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING SITE; COMPUTER SIMULATION; DENDRITIC CELL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL;

EID: 84863116812     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000093     Document Type: Article

References (47)

1. Lee CY, Sharma A, Cheong JE, Nelson JL (2009) Synthesis and antioxidant properties of dendritic polyphenols. Bioorg Med Chem Lett 19: 6326-6330.
2. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interac 16: 1-40.
3. Smith M (2008) MedPage Today, May 27, 2008.
4. Antioxidant Supplements for Cancer, 2006.
5. Kampa M, Nifli AP, Notas G, Alexaki VI, Hatzoglou A, Castanas E, 2006.
6. Solimani R (1996) Quercetin and DNA in solution: analysis of the dynamics of their interaction with a linear dichroism study. Int J Biol Macromol 18: 287-295.
7. Zhu Z, Li C, Li NQ (2002) Electrochemical studies of quercetin interacting with DNA. Microchem J 71: 57-63.
8. Marinić M, Piantanida I, Rusak G, Zinić M (2006) Interactions of quercetin and its lanthane complex with double stranded DNA/RNA and single stranded RNA: spectrophotometric sensing of poly G. J Inorg Biochem 100: 288-298.
9. Snyder RD, Gillies PJ (2002) Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ Mol Mutagen 40: 266-276.
10. Solimani R (1997) The flavonols quercetin, rutin and morin in DNA solution: UV-vis dichroic (and mid-infrared) analysis explain the possible association between the biopolymer and a nucleophilic vegetable-dye. Biochim Biophys Acta 1336: 281-294.
11. Benjamin P Sopczynski (2008) A New Anti-Tumor Drug Delivery System: Dendrimers. MMG 445 Bas Biotechn eJ 2:87-92.
12. Cheng Y, Xu Z, Ma M, Xu T (2008) Dendrimers as drug carriers: applications in different routes of drug administration. J Pharm Sci 97: 123-143.
13. McGhee JD, Von Hippel PH (1974) Theoretical aspects of DNA-protein interactions: cooperative and non-cooperative binding of large ligands to a onedimensional homogeneous lattice. J Mol Biol 86: 469-489.
14. Czarny A, Boykin DW, Wood AA, Nunn CM, Neidle S, et al. (1995) Analysis of van der Waals and Electrostatic Contributions in the Interactions of Minor Groove Binding Benzimidazoles with DNA. J Am Chem Soc 117: 4716-4717.
15. Brooks III CL, Karplus M, Pettitt BM (1988) Proteins: A Theoretical Perspective of Dynamics, Structure and Thermodynamics; Advances in Chemical Physics, Vol LXXI, New York 1988.
16. McCammon, JA, Harvey SC (1987) Dynamics of Proteins and Nucleic Acids. Cambridge University Press, New York.
17. Van Gunsteren, WF, Weiner PK (1989) Computer Simulation of Biomolecular Systems, Leiden: Escom.
18. Redinbo MR, Stewart L, Kuhn P, Champoux JJ, Hol WG (1998) Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279: 1504-1513.
19. Patel DJ, Shapiro L (1985) Molecular recognition in noncovalent antitumor agent-DNA complexes: NMR studies of the base and sequence dependent recognition of the DNA minor groove by netropsin. Biochimie 67: 887-915.
20. Bielawski K, Bielawska A, Bartulewicz D, Rózański A (2000) Molecular modelling of the interaction of carbocyclic analogues of netropsin and distamycin with d(CGCGAATTCGCG)2. Acta Biochim Polon 47: 855-866.
21. Buchko GW, Tung CS, McAteer K, Isern NG, Spicer LD, et al. (2001) DNA-XPA interactions: a (31)P NMR and molecular modeling study of dCCAATAACC association with the minimal DNA-binding domain (M98-F219) of the nucleotide excision repair protein XPA. Nucleic Acids Res 29: 2635-2643.
22. Lee HM, Kim JK, Kim SK (2002) Molecular modeling study of the norfloxacin- DNA complex. J Biomol Struct Dyn 9: 1083-1091.
23. Sellner B, Zifferer G, Kornherr A, Krois D, Brinker UH (2008) Molecular dynamics simulations of beta-cyclodextrin-aziadamantane complexes in water. J Phys Chem B 112: 710-714.
24. Kolossváry GJ, Kolossváry I (1996) Biotech Lett 18: 440-444.
25. version 4.4 Accelrys Inc. San Diego, U.S.A.
26. Schwartz G, Klose S, Baltasan W (1970) Cooperative binding to linear biopolymers. 2. Thermodynamic analysis of the proflavine-poly(L-glutamic acid) system. Eur J Biochem 12: 454-460.
27. Wakelin LPG, Chetcuti P and Denny WA (1990) Kinetic and equilibrium binding studies of amsacrine-4-carboxamides: a class of asymmetrical DNAintercalating agents which bind by threading through the DNA helix. J Med Chem 33: 2039-2044.
28. Weiner SJ, Kollman PA, Nguyen DT and Case DA (1986) J Comput Chem 7: 230-252.
29. Yang W, Cheng Y, Xu T, Wang X, Wen LP, et al. (2009) Targeting cancer cells with biotin-dendrimer conjugates. Eur J Med Chem 44: 862-868.
30. Berry CC (2005) Possible exploitation of magnetic nanoparticle-cell interaction for biomedical applications. J Mater Chem 15: 543-547.
31. Rohs R, Skelnar H (2001) Methylene blue binding to DNA with alternating GC base sequence: continuum treatment of salt effects. Indian J Biochem Biophys 38: 1-6.
32. Crenshaw JM, Graves DE, Denny WA (1995) Interactions of acridine antitumor agents with DNA: binding energies and groove preferences. Biochemistry 34: 13682-13687.
33. Maus M, Wagner KG, Kornherr A, Zifferer G (2008) Molecular dynamics simulations for drug dosage form development: thermal and solubility characteristics for hot-melt extrusion. Molecular simulation 34: 1197-1207.
34. Sun Y, Mo Z, Chen H, Guo R, Qiao L, Li H (2009) Molecular dynamics simulation of temperature effect on dendrimer/NanoGs/PPy interface material. Computnl mat Sci 46: 162-166.
35. Levy RM, Gallicchio E (1998) Computer simulations with explicit solvent: recent progress in the thermodynamic decomposition of free energies and in modeling electrostatic effects. Annu Rev Phys Chem 49: 531-67.
36. Sherman W, Day T, Jacobson M, Friesner R, Farid R (2006) Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 49: 534-553.
37. Berendsen HJC, Postma JPM, van Gunsteren, WF, DiNola, A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81: 3684.
38. Russo M, Spagnuolo C, Volpe S, Mupo A, Tedesco I, et al. (2010) Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients. Brit J Can 103: 642-648.
39. Perun T, Propst CL (1989) Computer Aided Drug Design, Marcel Dekker, Inc., New-York.
40. Cohen NC (1995) Guide Book on Molecular Modelling in Drug Design, Academic Press.
41. Hockney RW, Eastwood JW (1998) Computer simulations using particles. New York:Adam Hilger.
42. Kitae, T, Takashima H, Kano K (1999) Chiral Recognition of Phenylacetic Acid Derivatives by Aminated Cyclodextrins. J Inclusion Phenom Macrocyclic Chem 33: 345-359.
43. Lamson WD, Brignall MS (2000) Antioxidants and Cancer III:Quercetin. Alt Med Rev 5: 196-208.
44. Kujawski M, Howell B, Chai M, Mueller A, Kujawski M, et al. (2008) Computeraided applications of nanoscale smart materials for biomedical applications. Nanomedicine 3: 719-739.
45. Bohin J, Ternaux JP (2002) Effects of temperature on the early stages of rat spinal motoneurone development in vitro. Neurosci Lett 329: 106-110.
46. The Effect of Quercetin in Sarcoidosis (2008) Clinica Trials, USA.
47. Murakami A, Ashida H, Terao J (2008) Multitargeted cancer prevention by quercetin. Cancer Lett 269: 315-325.